Wyeth

Indentures Filter

EX-4.1
from 8-K 4 pages Eighth Supplemental Indenture, Dated as of October 30, 2009 (This “Eighth Supplemental Indenture”), Between Wyeth, a Delaware Corporation (As Successor to American Home Products Corporation) (The “Issuer”), Pfizer Inc., a Delaware Corporation (“Pfizer”) and the Bank of New York Mellon (As Successor to Jpmorgan Chase Bank), a Banking Corporation Duly Organized and Existing Under the Laws of the State of New York, as Trustee (The “Trustee”)
12/34/56
EX-4.1
from 8-K 15 pages Seventh Supplemental Indenture, Dated as of March 27, 2007 (This “Seventh Supplemental Indenture”), Between Wyeth, a Delaware Corporation (Formerly Known as American Home Products Corporation) (The “Issuer”) and the Bank of New York (As Successor to Jpmorgan Chase Bank), a Banking Corporation Duly Organized and Existing Under the Laws of the State of New York, as Trustee (The “Trustee”)
12/34/56
EX-4.4
from S-4 17 pages $1,500,000,000 Wyeth $1,000,000,000 5.50% Notes Due 2016 $500,000,000 6.00% Notes Due 2036 Exchange and Registration Rights Agreement
12/34/56
EX-4.3
from S-4 38 pages Sixth Supplemental Indenture, Dated as of November 14, 2005 (This “Sixth Supplemental Indenture”), Between Wyeth (As Successor to American Home Products Corporation), a Delaware Corporation (The “Issuer”) and Jpmorgan Chase Bank, N.A. (As Successor to Manufacturers Hanover Trust Company), as Trustee (The “Trustee”)
12/34/56
EX-4.1
from 8-K ~20 pages Sixth Supplemental Indenture, Dated as of November 14, 2005 (This “Sixth Supplemental Indenture”), Between Wyeth (As Successor to American Home Products Corporation), a Delaware Corporation (The “Issuer”) and Jpmorgan Chase Bank, N.A. (As Successor to Manufacturers Hanover Trust Company), as Trustee (The “Trustee”)
12/34/56
EX-4.6
from 10-K ~10 pages Fifth Supplemental Indenture
12/34/56
EX-4.4
from S-3 ~20 pages Registration Rights Agreement
12/34/56
EX-4.3
from S-3 ~50 pages Supplemental Indenture
12/34/56
EX-4.2
from 8-A12B/A 1 page Amendment to Rights Agreement
12/34/56
EX-4.4
from 10-K ~10 pages Third Supplemental Indenture
12/34/56
EX-4.1
from 8-A12B/A ~50 pages Amended & Restated Right Agr
12/34/56
EX-4.4
from S-4 ~20 pages Exchange and Reg. Rights Agreement
12/34/56
EX-4.3
from S-4 ~50 pages Second Supplemental Indenture
12/34/56
EX-4.3
from 8-A12B/A ~5 pages Indenture or similar
12/34/56
EX-4.2
from 8-A12B ~5 pages Indenture or similar
12/34/56
EX-4.1
from 8-A12B ~50 pages Indenture or similar
12/34/56
EX-4
from SC 13D/A 1 page Indenture or similar
12/34/56
EX-4
from SC 13D/A 1 page Letter to Immunex Chairman
12/34/56
EX-4.(D)
from S-3 ~10 pages Indenture or similar
12/34/56
EX-4.(C)
from S-3 ~20 pages Indenture or similar
12/34/56